Conflicts seen on guidelines panel

The AHA/ACC panel that wrote the potentially practice-changing cholesterol guidelines issued last month included six members with ties to drugmakers that sell or are developing lipid medications, Pharmalot reported. Each disclosed they worked as a consultant and received funding for personal research.

Among the 10 expert reviewers, half listed consulting relationships with such companies cited as Merck, Amgen, AstraZeneca, Pfizer, Amarin, Roche and Abbott Laboratories, whose cholesterol pills are sold by AbbVie. An AHA spokeswoman responded that none of the ACC/AHA expert reviewers had “relevant” relationships with industry.

You must be a registered member of MMM to post a comment.

Content marketing is not advertising in the old sense. In its use of social media, content marketing challenges consumers while relying on their input. It is proactive and responsive to their concerns, needs and energy. Content marketing has become the new voice of marketing. Learn what you need to know and how pharma marketers can adapt to this innovative venture into social media by clicking here for access.

Email Newsletters